Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H23NO2 |
Molecular Weight | 261.3593 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(CO[C@@](CC)(O1)C2=CC=CC=C2)[C@]3([H])CCCCN3
InChI
InChIKey=INOYCBNLWYEPSB-XHSDSOJGSA-N
InChI=1S/C16H23NO2/c1-2-16(13-8-4-3-5-9-13)18-12-15(19-16)14-10-6-7-11-17-14/h3-5,8-9,14-15,17H,2,6-7,10-12H2,1H3/t14-,15+,16-/m0/s1
Molecular Formula | C16H23NO2 |
Molecular Weight | 261.3593 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16169732 |
19.8 null [Ki] |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5921
0.75 mg/kg
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:49:12 GMT 2023
by
admin
on
Sat Dec 16 14:49:12 GMT 2023
|
Record UNII |
RO44G6QT80
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID00865419
Created by
admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
|
PRIMARY | |||
|
30163-01-0
Created by
admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
|
PRIMARY | |||
|
14208380
Created by
admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
|
PRIMARY | |||
|
RO44G6QT80
Created by
admin on Sat Dec 16 14:49:12 GMT 2023 , Edited by admin on Sat Dec 16 14:49:12 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|